sulfasalazine has been researched along with Orphan Diseases in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Orphan Diseases: Rare diseases that have not been well studied.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsing, YE | 1 |
| Walker, J | 1 |
| Hoversten, P | 1 |
| Beachey, J | 1 |
| Pham, M | 1 |
| Bhagra, A | 1 |
2 other studies available for sulfasalazine and Orphan Diseases
| Article | Year |
|---|---|
Bilateral interstitial keratitis with anterior stromal infiltrates associated with reactive arthritis.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Corneal Strom | 2017 |
A rare cause of oligoarthritis with septic presentation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Diarrhea; Dysuria; Fever; Gastr | 2018 |